Skip to content
healthcare.dev

OXCARBAZEPINE

NDC 72888-074, OXCARBAZEPINE, suspension, from Advagen Pharma Ltd.

Product NDC
72888-074
Status
Listed
Labeler
Advagen Pharma Ltd
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215726
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72888-074 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXCARBAZEPINE300 mg/5mL

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
72888-074-14728880074141 BOTTLE in 1 CARTON (72888-074-14) / 250 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4ef6a941-a017-40f2-a50a-ab66c43b3347
  • NADAC price for package 72888007414

    GET /v1/drugs/nadac/72888007414

Use it

Look up 72888-074 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72888-074 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72888-074. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.